(1). The retina contains two types of photoreceptors called rods and cones. Rod photoreceptors are light sensitive and abundant in the retina. In contrast, cone photoreceptors are active only at higher levels of light and are scarce in the retinal layer (2). AMD impairs cone photoreceptors with no means to regenerate and this may eventually lead to the damage of other retinal cells (1) . Preceding research has shown that human embryonic stem (hES) cells and induced pluripotent stem 
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Background Age Related Macular Degeneration:
Many forms of eye diseasess causing visual impairment exist in the United States. Amongst the retinal degenerative diseases, the National Eye Institute recognizes age related macular degeneration (AMD) as the leading cause of blindness for people 50 years or older. The two main types of AMD are dry and wet. Dry AMD is distinguished by an accumulation of yellow protein deposits known as drusen, while, wet AMD is recognized by new blood vessel growth, a part of the body's natural healing response. These abnormal vessels usually grow in an unstable fashion and are leaky, allowing blood to enter into the eye, causing further visual impairment (1) .
Regardless of the type of AMD, this form of retinal degenerative disease is aggressive and ultimately causes damage to the central vision as shown in figure   1 . About 14% of people who have dry AMD develop the wet form over time, which is more progressive (1) . Currently, there are treatment options for the wet form, including taking high doses of vitamins or minerals, injections of antivascular endothelial growth factor into the eye, or some form of laser surgery.
However, these treatments only help ablate the abnormal blood vessel formation, and often leave some scaring which further impedes central vision. To date, there is no cure for AMD. Furthermore, the cells that are harmed or destroyed by the AMD disease do not have the capacity to regenerate on their own. Thus once a cell is damaged, it is lost forever. The ability to regenerate lost cells using stem cell therapy is seen as a potential viable solution (2). In this study, we proposed a method for developing cells in vitro that could replace cells damaged by retinal degenerative diseases, such as AMD.
The Retina:
The retina, a pseudostratified epithelial membrane that lines the back of the eye, is vulnerable to a variety of retinal degenerative diseases such as AMD. This membrane is viable to vision because it is light sensitive, which allows for image processes to occur (3). The cells responsible for vision are known as photoreceptors and respond to light photons. Light travels through the thick layers of the retina before triggering the photoreceptors (figure 2). The absorption of photons by the photoreceptors is first translated into a biochemical message and then an electrical message which stimulates all the downstream neurons of the retina. When this biochemical message reaches the ganglion cells, its long axons, that make the up the optic nerve, help transport the information to the brain, which is then perceived into an image (4).
As stated earlier, photoreceptors are the cells involved in visual response.
The two types of photoreceptors are the rods and cones. Both photoreceptors are located throughout the retina including the macula, an area in the center of the retina. Rod photoreceptors are extremely light sensitive, and only detect the presence or absence of light; rods are responsible for black and white vision and are vastly abundant, with approximately 120 million rods found around the periphery of the macula (5). On the other hand, cones reside in the fovea, the central area of the macula (figure 2B). Cones make up the majority of central vision and respond to high levels of light. Often referred to as the color photoreceptors, the cones are far less abundant then rods, with an estimate of about 6 to 7 million in the retina and enriched around the macula and fovea (6) .
Since AMD causes damage to the area known as the macula, and more specifically, the fovea, this disease primarily targets and damages cone photoreceptors. The picture to the left shows the light sensitive layer at the back of the eye known as the retina. The picture to the right demonstrates how light travels through this pseudostratified layer and reaches the photoreceptors, which send a signal back to the brain through the optic nerve. (B) The picture to the left shows the optic nerve and close by an area in the center of the retina known as the macula. The picture to the right demonstrates a head on view of the macula and the photoreceptors that occupy it.
Stem Cell Research:
Vision restoration through stem cell transplantation has been a vastly studied area of interest. This could be an applicable therapeutic approach for many retinal degenerative diseases such as AMD. In order for treatment to be successful, the regeneration of retinal cells needs to be accomplished first. The growth and development of retinal neural cells, including rod photoreceptors in vitro using stem cells have been developed by several research groups including the Lamba lab (7). However, the specific growth of cone photoreceptor cells in vitro has not yet been successful for several reasons, especially because the exact genes and specific pathways that regulate cone identity are unknown. Successful development of these cells are essential for many reasons. First, photoreceptor cells are in close proximity to each other and studies have shown that damage to one neuronal cell is able to affect an adjacent neuronal cell (8) . These types of damages could lead to other diseases such as retinitis pigmentosa that affect rod Mammalian retinal differentiation can be achieved in many ways by altering several signaling pathways. Forebrain and retinal development involves the coinhibiting bone morphogenetic protein (BMP) and Wnt signaling pathways (13) .
In support of this Barrantes and others demonstrated that mice expressing mutated dickkopf1 (dkk1) and noggin, two known BMP and Wnt antagonists, developed major head and eye defects.
Furthermore, the Notch-Delta pathway has been shown to be essential for inducing retinal progenitor cells (14) , whereas insulin like growth factor-1 (IGF-1) has been shown to be necessary for eye development (15) . Osakada and others established a protocol demonstrating the use of specific small molecules to induce retinal differentiation as an efficient and cost effective way to produce photoreceptors, which has been replicated in our lab (16) . The small molecules used were SB4131542, IWR-1, and LDN193189 along with IGF1 (a recombinant protein). These small molecules and protein are collectively known as ISLI. and Recoverin (REC) (17) . More specifically thyroid hormone receptor beta 2 (Thrb2) and retinoid receptor X gamma (RXRG) are cone photoreceptor specific markers (18) .
Cone Photoreceptor Development:
During neural retinal differentiation via hES or iPS cells in vitro, many specific genes are upregulated at various time points, which likely explains the genesis of some retinal cells (17, 18) . Cone photoreceptors are one of the first cells developed during retinal neurogenesis (19) . However, the exact genes that bias cone photoreceptor development still remain unclear. Understanding which photoreceptor genes are expressed early on could offer insights into the origin of cone cells and could elucidate the development of cone photoreceptor cells from hES or iPS cells in vitro.
Unpublished data from our collaborator, Dr. Joseph Brzezinski (Colorado University, Colorado, CA), identified three early possible cone photoreceptor transcription factors through RNA sequencing. This initial data was obtained using differentiated mouse retinal stem cells where notch signaling was inhibited at day 14.5, and thus driving retinal neural induction. Birthing studies demonstrated that this specific time point was seen to give rise to a peak in cone photoreceptor development (20) . OTX2, a known photoreceptor gene, ONECUT1, and BLIMP were all upregulated synchronously at 14.5 days during 10,12, and 18 hours following notch inhibition. Trb2, a mature cone photoreceptor marker, was upregulated later at 48 hours. This preliminary analysis suggested that OTX2, ONECUT1, and BLIMP could potentially be responsible for biasing cone photoreceptor cell fate. Further studies were necessary in order to develop a solid understanding of whether and how these genes may contribute to retinal cell progenitor fate and cone photoreceptor development.
The goal of this study is to investigate whether cone photoreceptor cells can be developed in vitro by overexpressing OTX2, ONECUT1, and BLIMP using differentiated retinal neural stem cells. This overexpression was done through messenger ribonucleic acid (mRNA) transient transfection of the three genes.
Using mRNA has many advantages, in that 1) mRNA will not harm the host genome, 2) mRNA does not need to be localized in the nucleus and 3) it allows for faster interpretation of experimental results (21) . Although mRNA has its benefits, RNA is known to rapidly degrade, hence DNA transfections have been traditionally used more often. However, a recent study bypassed this problem where researchers confirmed their product (a stable RNA vector) could be transfected in human cells for a longer duration of about 36 hours (22) . Using mRNA for this research allowed us to study cone cell origin. Developing cone photoreceptor cells in vitro could potentially transform the way retinal degenerative diseases are studied and may potentially be used as a means for cell replacement therapy for diseases such as age related macular degeneration.
Materials and Methods
Plasmid Transformation
DNA plasmids (OTX2, ONECUT1, and BLIMP) were provided by Dr.
Joseph Brzezinski (University of Colorado, Boulder, CO). Plasmids were used to transform competent One Shot E. coli bacteria (Thermo Fisher, Cincinnati, OH), using manufacture's protocol. Bacteria were plated on Luria Broth (LB) media (Thermo Fisher, Cincinnati, OH) supplemented with either ampicillin or kanamycin, depending on resistance. Plates were incubated overnight at 37˚C.
From each transformation, three bacterial colonies were picked the following day and grown for 1 hour at 37˚C in 15-ml of LB media containing the matching antibiotic. This bacterial culture was then used to inoculate 250 ml of LB media containing the corresponding antibiotic (1:1000 µg/µl). The flask was incubated overnight at 37˚C in a Thermo Scientific MaxQ 8000 bacterial shaker.
DNA Extraction
Plasmid DNA was purified using the Maxi kit (IBI Scientific, Peosta, IA) according to the manufacturer's protocol. The DNA pellet was re-suspended in 300 µL of elution buffer. The DNA was quantified via Thermo Scientific NanoDrop 2000 Spectrophotometer.
DNA Enzyme Digest and Extraction
DNA enzyme digestion reactions were setup as follows: 24 µg of purified plasmid DNA, 6 µl of Nhe1, 10 µl of BSA, 1 µl of 2.1 Buffer, and diethylpyrocarbonate (DEPC) water to bring the total volume to 100 µl. Nhe1, bovine serum albumin (BSA), 2.1 Buffer were purchased through New England BioLabs (Ipswich, MA). The samples were placed in a 100-µl PCR tube and incubated for 4 hours at 37˚C, followed by 15 minutes at 65˚C in a T100 Thermo cycler (Biorad, Hercules, CA) to inactivate the NheI restriction enzyme. Enzyme digestions were confirmed with a 1.5% LE quick dissolve agarose electrophoresis gel (GeneMate, Kaysville, UT), running at 100V for 30 minutes. 100 µl of the digested DNA was mixed with 100 µl of 1:1 phenol-chloroform in a 1.7-ml eppendorf tube for DNA extraction. The mixture was centrifuged for 5 minutes at 11,000 RPM. The upper layer was transferred to a new eppendorf tube and washed with 1 mL of 100% ethanol. This was centrifuged at 11,000 RPM for 10 minutes to obtain a DNA pellet, which was re-suspended in 30 µl of (DEPC) water and quantified via nano spectrometry.
Messenger RNA Synthesis
Nhe1 cut DNA plasmids (control CHERRY, BLIMP, ONECUT1, and OTX2) were run through the HiScribe T7 ARCA mRNA kit according to the manufacturer's protocols for mRNA synthesis. Synthesized mRNA was resuspended in 50 µl of RNase-free water and quantified through nano spectrometry. A 1.5% agarose electrophoresis gel (GeneMate) was done in order to confirm the quality of RNA bands.
Retinal differentiation of human embryonic stem cells
Human embryonic stem cell lines (hESC) H1 and WA01) were purchased ng of total RNA was used, and the rest of the kit's instructions were followed. The reactions were incubated in a T100 Thermal Cycler machine per kit's instructions.
Quantitative RT-PCR. Analysis was performed on the CFX Connect Real Time PCR Detection System (BioRad). Primers used in this study are listed in Table 1 . Following the washes, samples were blocked with a block solution consisting of 1X PBS and 10% normal donkey serum (EMD; Millipore Darmstadt, Germany)
for one hour. Primary antibodies were diluted in blocking solution according to 
Animal Transplantation and Samples
Human retinal stem cells were generated using the differentiation protocol, infected with GFP plasmid and transfected using the transfection protocol. The cells were exported and implanted into IL2rg null mice (graciously performed and provided by Dr. Jie Zhu, Buck Institute for Research on Aging, Novato, CA).
Upon receiving mouse retina samples, staining for photoreceptors was carried out with the immunohistochemistry previously described."
Results
Development of the Neural retinal stem cell differentiation protocol:
The Lamba lab has established several retinal neural differentiation protocols using both hES and iPS cells. The specific protocol chosen here used four molecules to drive neural retinal differentiation ( Figure 3A ). These molecules differentiated stem cells in a less costly and more accelerated manner, where differentiation is only happening for a few days as opposed to weeks. In this particular investigation, the human embryonic stem cell line referred to as H1 cells was the main cell type used for neural retinal differentiation. However, an iPS cell line called Lonza, generously donated by the Zeng lab at the Buck Institute (Novato, CA) was also used for the same experiments (data not shown).
The results below correspond to H1 cells; however, the data for the Lonza cells 
Synthesis of mRNA and working parameters for transient transfection:
Transfection protocols typically involve transfecting DNA, however, for the experiments in this project, mRNA was used instead. As mentioned in the introduction, there are multiple advantages for selecting mRNA. Here, we used Figure 4B ). Once the transfections parameters were established, GFP transfection was then tested on the H1, the human neural retinal differentiated cell line that would be used for the remainder of the study. Results in figure 4C showed that the same conditions ( Figure 4B ) were able to successfully transfect the differentiated hES cell line with little to no cell death and the majority of the cells had GFP ( figure 4C ).
Next, the HEK cells were transfected with the control mRNA, CHERRY.
CHERRY is another fluorescent marker like GFP, except it fluoresces red. was observed the first day after transfection (Figure 5A ).
The strong expression of CHERRY protein was sustained five days after transfection, then the expression slowly decreased after 5 days, until it completely disappeared around day 14. Normal media changes were done and no cell death was observed during the 14 day period (data not shown). RNA was extracted on day 5, day 7, day 10 and day 14. On day 7, qRT-PCR data showed a seven-fold increase in CHERRY expression in transfected H1 cells compared to mock transfected cells ( Figure 5B ). RNA was also analyzed for the other days using qRT-PCR, and consistent with the fluorescent microscopy, the CHERRY expression gradually decreased until 14 days post-transfection (data not shown).
This data confirmed that the transient mRNA transfections were successful in the human embryonic stem cell-derived retinal neural stem cells (3 months of age) and that expression of the gene of interest occurred after no more than 7 days post transfection. Therefore, we proceeded with the main objective of our experiment, overexpressing the three early retinal genes (BLIMP, ONECUT1, OTX2) in order to bias cone photoreceptor cell fate. To further analyze whether these three early genes work together, we performed additional transfection of these genes in combinations or two or three.
OC1 and OTX2 mRNAs were transfected together using the established protocol.
This double transfection resulted in a four to five fold increase in OC1 and OTX2
expressions and a one fold increase in BLIMP expression. It was interesting to note that the double transfection did not drive OC1 or OTX2 expression significantly more than the single mRNA transfections; similarly, BLIMP was also expressed in the double transfection (OCI and OTX2 together) as it was in the single OC1 or OTX2 mRNA transfections. When all three mRNAs (BLIMP, OC1, and OTX2) were transfected, cells showed an equal expression (4-64 fold increase) of all three genes ( Figure 6C ). Furthermore, transfecting all three mRNA consistently resulted in similar expression levels for all three genes, while the double transfection often resulted in more varied results (data not shown).
Therefore, subsequent transfections in this study consisted of all three mRNAs, which will be referred to as "BOO," for BLIMP, ONECUT1 and OTX2 ( Figure   6C ). Using this data, we created an H1 cell mRNA transfection protocol which is depicted in figure 6B. Moreover, the expression of specific cone photoreceptor factors thyroid hormone receptor beta (TRB2) and Retinoid X Receptor, Gamma (RXRG) were also upregulated ( Figure 7A ).
While qRT-PCR confirmed that the "BOO" triplicate transfected cells were expressing photoreceptor factors at the mRNA level, immunohistochemistry was carried out to assess expression level at the protein level for each of the corresponding genes. One week after transfection, higher levels of otx2 and recoverin proteins, both photoreceptor markers, were seen in "BOO" transfected cells when compared to non-transfection control cells. More importantly, RXRG protein, an indicator of cone photoreceptor expression, was also noticed ( Figure   7B ). This translation further demonstrated that expression of "BOO" not only influenced mRNA expression levels of cone photoreceptor associated genes, but also resulted in a corresponding expression at the protein level. Furthermore, these results confirmed that "BOO" mRNA expression could be sustained over a period of about a week. This data suggested that one week of "BOO" overexpression may play an important role in cone photoreceptor development in H1 differentiated neural retinal stem cells. Moreover, future research and treatment is geared towards more personalized therapeutics. Experiments that entail hES and iPS cells have grown popular for such studies. Lastly, using RNA treatments which will not harm the genome and provide a more stabilized treatment method could mean more promising therapy results.
